Sheila Gujrathi Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sheila Gujrathi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sheila Gujrathi. Sheila Gujrathi is a Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and a Chief Medical Officer in Receptos, Inc. ($RCPT) and a Director in Turning Point Therapeutics, Inc. ($TPTX) and a President & CEO in Gossamer Bio, Inc. ($GOSS).
Address: C/O RECEPTOS, INC. 10835 ROAD TO THE CURE, SUITE 205 SAN DIEGO 92121 CA
Companies in which Sheila Gujrathi is an Insider
FIVE PRIME THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sheila Gujrathi: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 14 2018
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Gossamer Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sheila Gujrathi: President & CEO
Holdings: 189,500 shares
Latest Transaction: Feb 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Receptos, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sheila Gujrathi: Chief Medical Officer
Holdings: 0 shares
Latest Transaction: Aug 27 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Turning Point Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sheila Gujrathi: Director
Holdings: 0 shares
Latest Transaction: Jun 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sheila Gujrathi
Sentiment: All, FPRX, GOSS, RCPT, TPTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2020 | TPTX | Turning Point Ther ... | Gujrathi Sheila | Director | Option Exercise | A | 65.39 | 8,500 | 555,815 | 8,500 | |
| Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | A | 14.55 | 292,000 | 4,248,600 | 292,000 | |
| Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Grant | A | 0.00 | 189,500 | 0 | 189,500 | 0 to 189.5 K |
| Sep 27 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Buy | P | 16.80 | 10,000 | 167,980 | 4,048,242 | 4 M to 4 M (+0.25 %) |
| Apr 24 2019 | TPTX | Turning Point Ther ... | Gujrathi Sheila | Director | Option Exercise | A | 27.06 | 15,000 | 405,900 | 15,000 | |
| Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | A | 22.10 | 380,000 | 8,398,000 | 380,000 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | C | 0.00 | 55,957 | 0 | 0 |